ER : estrogen receptor, PR : progesterone receptor, IDC : Infiltrative ductal carcinoma, ILC : Infiltrative lobular carcinoma, HER2 : human epidermal growth factor receptor 2, NACT : neoadjuvant chemotherapy. This evidence concerns the gene ERBB2 and breast ductal adenocarcinoma.